 Tellen Bennett
Concepts (292)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 15 | 2023 | 301 | 5.250 |
Why?
| | Intracranial Pressure | 7 | 2022 | 46 | 2.670 |
Why?
| | Intensive Care Units, Pediatric | 12 | 2022 | 147 | 2.520 |
Why?
| | Brain Injuries | 8 | 2018 | 451 | 2.430 |
Why?
| | Sepsis | 9 | 2024 | 515 | 2.390 |
Why?
| | Intracranial Hypertension | 4 | 2022 | 38 | 1.940 |
Why?
| | Critical Care | 6 | 2023 | 477 | 1.780 |
Why?
| | Decision Support Systems, Clinical | 4 | 2023 | 179 | 1.770 |
Why?
| | Hospital Mortality | 15 | 2024 | 779 | 1.710 |
Why?
| | Child | 60 | 2024 | 18488 | 1.680 |
Why?
| | Machine Learning | 5 | 2023 | 321 | 1.560 |
Why?
| | Aftercare | 4 | 2024 | 187 | 1.490 |
Why?
| | Seizures | 3 | 2018 | 344 | 1.440 |
Why?
| | Databases, Factual | 14 | 2023 | 1138 | 1.390 |
Why?
| | Shock, Septic | 4 | 2024 | 185 | 1.130 |
Why?
| | Critical Illness | 8 | 2022 | 645 | 1.070 |
Why?
| | Child, Preschool | 28 | 2024 | 9133 | 1.050 |
Why?
| | Infant | 28 | 2022 | 7979 | 1.020 |
Why?
| | Monitoring, Physiologic | 3 | 2019 | 250 | 1.010 |
Why?
| | Humans | 95 | 2024 | 115586 | 1.010 |
Why?
| | Respiration, Artificial | 5 | 2022 | 526 | 0.940 |
Why?
| | Recovery of Function | 3 | 2019 | 577 | 0.940 |
Why?
| | Pediatrics | 4 | 2023 | 986 | 0.900 |
Why?
| | Outpatients | 6 | 2023 | 330 | 0.900 |
Why?
| | Retrospective Studies | 30 | 2024 | 12608 | 0.870 |
Why?
| | Multiple Organ Failure | 6 | 2024 | 144 | 0.840 |
Why?
| | Connective Tissue Diseases | 1 | 2023 | 71 | 0.810 |
Why?
| | Severity of Illness Index | 5 | 2022 | 2578 | 0.730 |
Why?
| | Forecasting | 2 | 2021 | 333 | 0.710 |
Why?
| | Bacterial Infections | 1 | 2022 | 222 | 0.710 |
Why?
| | Trauma Severity Indices | 3 | 2017 | 111 | 0.700 |
Why?
| | Adolescent | 27 | 2023 | 17889 | 0.700 |
Why?
| | Wounds and Injuries | 5 | 2019 | 725 | 0.700 |
Why?
| | Infant, Newborn | 15 | 2017 | 5077 | 0.670 |
Why?
| | Disability Evaluation | 2 | 2018 | 271 | 0.650 |
Why?
| | Male | 41 | 2024 | 55949 | 0.650 |
Why?
| | Female | 42 | 2024 | 59913 | 0.650 |
Why?
| | Hospitalization | 6 | 2022 | 1765 | 0.640 |
Why?
| | Pandemics | 5 | 2023 | 1334 | 0.630 |
Why?
| | Electronic Health Records | 7 | 2023 | 805 | 0.630 |
Why?
| | Specialties, Surgical | 1 | 2019 | 71 | 0.620 |
Why?
| | Tranexamic Acid | 1 | 2018 | 40 | 0.620 |
Why?
| | Patient Discharge | 8 | 2024 | 770 | 0.610 |
Why?
| | Hypothermia, Induced | 1 | 2018 | 69 | 0.590 |
Why?
| | Neurophysiological Monitoring | 1 | 2017 | 10 | 0.580 |
Why?
| | Child Health | 1 | 2019 | 133 | 0.580 |
Why?
| | Nurses | 1 | 2019 | 151 | 0.570 |
Why?
| | Neurosurgical Procedures | 2 | 2023 | 157 | 0.570 |
Why?
| | Algorithms | 4 | 2023 | 1490 | 0.570 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 273 | 0.560 |
Why?
| | Organ Dysfunction Scores | 5 | 2024 | 39 | 0.550 |
Why?
| | Computer Security | 2 | 2021 | 18 | 0.550 |
Why?
| | Chronic Disease | 2 | 2022 | 1598 | 0.540 |
Why?
| | Health Services Research | 1 | 2019 | 377 | 0.530 |
Why?
| | Health Status Indicators | 1 | 2016 | 155 | 0.520 |
Why?
| | Patient Readmission | 2 | 2018 | 609 | 0.510 |
Why?
| | Physicians | 1 | 2023 | 776 | 0.510 |
Why?
| | Anticonvulsants | 1 | 2017 | 181 | 0.500 |
Why?
| | Electroencephalography | 1 | 2017 | 365 | 0.500 |
Why?
| | Medical Record Linkage | 2 | 2015 | 53 | 0.490 |
Why?
| | Medical Records Systems, Computerized | 1 | 2015 | 90 | 0.480 |
Why?
| | Cohort Studies | 11 | 2023 | 4944 | 0.480 |
Why?
| | Child, Hospitalized | 1 | 2015 | 39 | 0.480 |
Why?
| | Glasgow Coma Scale | 5 | 2023 | 144 | 0.480 |
Why?
| | Hypertension | 1 | 2022 | 1064 | 0.480 |
Why?
| | United States | 16 | 2022 | 12295 | 0.480 |
Why?
| | Spinal Injuries | 1 | 2015 | 48 | 0.480 |
Why?
| | Models, Biological | 1 | 2021 | 1646 | 0.460 |
Why?
| | Software | 1 | 2018 | 541 | 0.460 |
Why?
| | Cervical Vertebrae | 1 | 2015 | 105 | 0.460 |
Why?
| | Mannitol | 2 | 2022 | 32 | 0.450 |
Why?
| | Decision Support Techniques | 1 | 2017 | 353 | 0.450 |
Why?
| | Supervised Machine Learning | 3 | 2023 | 11 | 0.450 |
Why?
| | Saline Solution, Hypertonic | 2 | 2022 | 53 | 0.440 |
Why?
| | Emergency Service, Hospital | 3 | 2021 | 1829 | 0.430 |
Why?
| | Macrophage Activation Syndrome | 1 | 2012 | 12 | 0.430 |
Why?
| | Speech Therapy | 1 | 2013 | 21 | 0.430 |
Why?
| | Physical Therapy Specialty | 1 | 2013 | 34 | 0.420 |
Why?
| | Arthritis, Juvenile | 1 | 2012 | 42 | 0.420 |
Why?
| | Injury Severity Score | 5 | 2018 | 458 | 0.410 |
Why?
| | Risk Factors | 10 | 2023 | 8697 | 0.410 |
Why?
| | Occupational Therapy | 1 | 2013 | 73 | 0.400 |
Why?
| | Ferritins | 1 | 2011 | 57 | 0.390 |
Why?
| | Brain | 2 | 2014 | 2370 | 0.390 |
Why?
| | Fluid Therapy | 1 | 2012 | 122 | 0.370 |
Why?
| | Inpatients | 2 | 2022 | 380 | 0.370 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 478 | 0.360 |
Why?
| | Models, Statistical | 1 | 2014 | 606 | 0.360 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2012 | 221 | 0.360 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2010 | 50 | 0.350 |
Why?
| | Phenotype | 5 | 2023 | 2829 | 0.350 |
Why?
| | Length of Stay | 4 | 2023 | 958 | 0.340 |
Why?
| | Prospective Studies | 6 | 2024 | 6264 | 0.340 |
Why?
| | Ki-67 Antigen | 2 | 2020 | 104 | 0.330 |
Why?
| | Prognosis | 5 | 2022 | 3339 | 0.330 |
Why?
| | Tomography, X-Ray Computed | 2 | 2015 | 2392 | 0.320 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2010 | 179 | 0.310 |
Why?
| | Proteome | 2 | 2022 | 345 | 0.310 |
Why?
| | Systemic Inflammatory Response Syndrome | 3 | 2024 | 71 | 0.300 |
Why?
| | Survival Rate | 4 | 2019 | 1650 | 0.290 |
Why?
| | Comorbidity | 2 | 2022 | 1473 | 0.280 |
Why?
| | Infant Equipment | 1 | 2006 | 7 | 0.280 |
Why?
| | Protective Devices | 1 | 2006 | 27 | 0.280 |
Why?
| | Qualitative Research | 2 | 2023 | 971 | 0.280 |
Why?
| | Transcriptome | 2 | 2022 | 736 | 0.270 |
Why?
| | Adult | 18 | 2023 | 30718 | 0.260 |
Why?
| | Disease Progression | 5 | 2023 | 2418 | 0.260 |
Why?
| | Accidents, Traffic | 2 | 2006 | 170 | 0.260 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2016 | 41 | 0.250 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2021 | 243 | 0.250 |
Why?
| | Logistic Models | 4 | 2018 | 1856 | 0.230 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 32 | 0.220 |
Why?
| | Microscopy | 2 | 2021 | 125 | 0.220 |
Why?
| | Lower Extremity | 1 | 2006 | 337 | 0.210 |
Why?
| | Vital Signs | 1 | 2022 | 36 | 0.200 |
Why?
| | Blood Pressure Determination | 1 | 2022 | 122 | 0.200 |
Why?
| | Focus Groups | 1 | 2023 | 393 | 0.200 |
Why?
| | Blood | 1 | 2022 | 97 | 0.200 |
Why?
| | Middle Aged | 8 | 2023 | 26999 | 0.200 |
Why?
| | Creatine | 1 | 2001 | 51 | 0.200 |
Why?
| | Survivors | 2 | 2022 | 404 | 0.190 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 49 | 0.190 |
Why?
| | Myocarditis | 1 | 2022 | 94 | 0.190 |
Why?
| | Alanine | 1 | 2021 | 103 | 0.190 |
Why?
| | Fractures, Bone | 1 | 2006 | 372 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 55 | 0.190 |
Why?
| | Interferons | 1 | 2022 | 152 | 0.190 |
Why?
| | Morbidity | 1 | 2022 | 278 | 0.190 |
Why?
| | Age Distribution | 1 | 2022 | 341 | 0.190 |
Why?
| | Common Data Elements | 1 | 2020 | 10 | 0.190 |
Why?
| | Body Temperature | 1 | 2001 | 211 | 0.190 |
Why?
| | Washington | 2 | 2011 | 134 | 0.190 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 71 | 0.180 |
Why?
| | Early Diagnosis | 1 | 2022 | 220 | 0.180 |
Why?
| | Intersectoral Collaboration | 1 | 2021 | 56 | 0.180 |
Why?
| | Social Determinants of Health | 1 | 2023 | 136 | 0.180 |
Why?
| | Physical Exertion | 1 | 2001 | 206 | 0.180 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2023 | 194 | 0.180 |
Why?
| | Aged | 8 | 2024 | 19251 | 0.180 |
Why?
| | Acute Lung Injury | 1 | 2023 | 300 | 0.180 |
Why?
| | Databases, Genetic | 1 | 2021 | 208 | 0.180 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2021 | 515 | 0.170 |
Why?
| | Registries | 2 | 2018 | 1770 | 0.170 |
Why?
| | Acute Disease | 1 | 2022 | 914 | 0.170 |
Why?
| | Young Adult | 6 | 2023 | 10470 | 0.170 |
Why?
| | Neurosurgeons | 1 | 2019 | 13 | 0.170 |
Why?
| | Dexamethasone | 1 | 2021 | 316 | 0.170 |
Why?
| | Antiviral Agents | 2 | 2023 | 651 | 0.170 |
Why?
| | Intensive Care Units | 2 | 2023 | 622 | 0.160 |
Why?
| | Cerebrovascular Circulation | 1 | 2021 | 202 | 0.160 |
Why?
| | Medicine | 1 | 2020 | 103 | 0.160 |
Why?
| | Critical Care Nursing | 1 | 2019 | 29 | 0.160 |
Why?
| | Information Dissemination | 1 | 2021 | 193 | 0.160 |
Why?
| | Programming Languages | 1 | 2018 | 22 | 0.160 |
Why?
| | Metabolome | 1 | 2021 | 287 | 0.160 |
Why?
| | Risk Assessment | 3 | 2017 | 2987 | 0.160 |
Why?
| | ROC Curve | 2 | 2023 | 451 | 0.150 |
Why?
| | Immunohistochemistry | 2 | 2020 | 1642 | 0.150 |
Why?
| | Maternal-Child Health Centers | 1 | 1997 | 9 | 0.150 |
Why?
| | User-Computer Interface | 1 | 2019 | 145 | 0.150 |
Why?
| | National Health Programs | 1 | 1997 | 20 | 0.150 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2019 | 220 | 0.140 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1440 | 0.140 |
Why?
| | Interviews as Topic | 1 | 2019 | 596 | 0.140 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2016 | 15 | 0.140 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2016 | 7 | 0.140 |
Why?
| | Heart Failure | 2 | 2023 | 1963 | 0.140 |
Why?
| | Cause of Death | 2 | 2018 | 368 | 0.140 |
Why?
| | Pneumonia | 1 | 2022 | 576 | 0.140 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 222 | 0.140 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4440 | 0.140 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 324 | 0.140 |
Why?
| | Trauma Centers | 2 | 2016 | 329 | 0.140 |
Why?
| | Propensity Score | 1 | 2017 | 225 | 0.140 |
Why?
| | Blood Pressure | 1 | 2022 | 1537 | 0.130 |
Why?
| | Cell Nucleus | 1 | 2019 | 553 | 0.130 |
Why?
| | Retinal Diseases | 1 | 2016 | 77 | 0.130 |
Why?
| | Medical Staff, Hospital | 1 | 2016 | 74 | 0.130 |
Why?
| | Hyperlipidemias | 1 | 2016 | 124 | 0.130 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1718 | 0.130 |
Why?
| | Women's Health | 1 | 1997 | 271 | 0.130 |
Why?
| | Comparative Effectiveness Research | 1 | 2016 | 130 | 0.130 |
Why?
| | Organizational Culture | 1 | 2016 | 121 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2023 | 2800 | 0.120 |
Why?
| | Regression Analysis | 1 | 2017 | 959 | 0.120 |
Why?
| | Military Personnel | 1 | 2001 | 525 | 0.120 |
Why?
| | Mass Screening | 1 | 2021 | 1024 | 0.120 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 39 | 0.110 |
Why?
| | Treatment Outcome | 4 | 2022 | 9159 | 0.110 |
Why?
| | Area Under Curve | 1 | 2014 | 278 | 0.110 |
Why?
| | Patient Safety | 1 | 2016 | 276 | 0.110 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1087 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1180 | 0.110 |
Why?
| | Quality of Life | 1 | 2024 | 2385 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1484 | 0.110 |
Why?
| | Deglutition | 1 | 2013 | 58 | 0.110 |
Why?
| | Mycophenolic Acid | 1 | 2012 | 81 | 0.100 |
Why?
| | Cyclophosphamide | 1 | 2012 | 218 | 0.100 |
Why?
| | Cyclosporine | 1 | 2012 | 169 | 0.100 |
Why?
| | Antibodies, Monoclonal | 3 | 2022 | 1265 | 0.100 |
Why?
| | Time Factors | 4 | 2019 | 6165 | 0.100 |
Why?
| | Gastrostomy | 1 | 2012 | 89 | 0.100 |
Why?
| | Quality of Health Care | 1 | 2016 | 576 | 0.100 |
Why?
| | Medical Audit | 1 | 2011 | 75 | 0.100 |
Why?
| | Datasets as Topic | 2 | 2022 | 99 | 0.100 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2014 | 220 | 0.100 |
Why?
| | Case-Control Studies | 3 | 2023 | 3022 | 0.090 |
Why?
| | Tracheostomy | 1 | 2012 | 100 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6417 | 0.090 |
Why?
| | Consensus | 2 | 2024 | 532 | 0.090 |
Why?
| | Patient Transfer | 1 | 2011 | 143 | 0.090 |
Why?
| | Antibodies, Viral | 2 | 2023 | 527 | 0.080 |
Why?
| | Age Factors | 3 | 2014 | 2907 | 0.080 |
Why?
| | Data Collection | 2 | 2022 | 636 | 0.080 |
Why?
| | Interleukin-1 | 1 | 2012 | 971 | 0.080 |
Why?
| | Gestational Age | 1 | 2010 | 757 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2098 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2011 | 497 | 0.070 |
Why?
| | Incidence | 1 | 2010 | 2335 | 0.060 |
Why?
| | Respiration | 1 | 2024 | 177 | 0.050 |
Why?
| | Health Facilities | 1 | 2023 | 70 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2022 | 80 | 0.050 |
Why?
| | Ritonavir | 1 | 2023 | 72 | 0.050 |
Why?
| | Health Insurance Portability and Accountability Act | 1 | 2022 | 13 | 0.050 |
Why?
| | International Classification of Diseases | 1 | 2023 | 118 | 0.050 |
Why?
| | Biochemical Phenomena | 1 | 2001 | 10 | 0.050 |
Why?
| | Data Accuracy | 1 | 2022 | 49 | 0.050 |
Why?
| | Treatment Failure | 1 | 2022 | 332 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 334 | 0.050 |
Why?
| | Access to Information | 1 | 2021 | 50 | 0.050 |
Why?
| | Ethics Committees, Research | 1 | 2021 | 38 | 0.050 |
Why?
| | Government Regulation | 1 | 2021 | 45 | 0.050 |
Why?
| | Health Resources | 1 | 2022 | 122 | 0.050 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2021 | 107 | 0.050 |
Why?
| | Los Angeles | 1 | 2020 | 56 | 0.050 |
Why?
| | Data Mining | 1 | 2021 | 100 | 0.040 |
Why?
| | Delphi Technique | 1 | 2020 | 164 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 21 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 1086 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1227 | 0.040 |
Why?
| | Patient Admission | 1 | 2019 | 175 | 0.040 |
Why?
| | Neuroendocrine Tumors | 1 | 2019 | 83 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 448 | 0.040 |
Why?
| | Body Composition | 1 | 2001 | 580 | 0.040 |
Why?
| | Biomedical Research | 1 | 2023 | 588 | 0.040 |
Why?
| | North Carolina | 1 | 1997 | 97 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2022 | 684 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2001 | 1660 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 691 | 0.040 |
Why?
| | Policy Making | 1 | 1997 | 82 | 0.040 |
Why?
| | Fundus Oculi | 1 | 2016 | 40 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 538 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 2016 | 55 | 0.030 |
Why?
| | Remission Induction | 1 | 2016 | 240 | 0.030 |
Why?
| | Health Care Surveys | 1 | 1997 | 538 | 0.030 |
Why?
| | Pancreatitis | 1 | 2016 | 107 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 859 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1536 | 0.030 |
Why?
| | Health Education | 1 | 1997 | 325 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2416 | 0.030 |
Why?
| | Coroners and Medical Examiners | 1 | 1994 | 7 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2014 | 22 | 0.030 |
Why?
| | Death Certificates | 1 | 1994 | 30 | 0.030 |
Why?
| | Societies, Medical | 1 | 1997 | 684 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2014 | 128 | 0.030 |
Why?
| | Risk Adjustment | 1 | 2014 | 75 | 0.030 |
Why?
| | Biomarkers | 1 | 2023 | 3466 | 0.030 |
Why?
| | Cross Infection | 1 | 2015 | 202 | 0.030 |
Why?
| | Program Evaluation | 1 | 1997 | 836 | 0.030 |
Why?
| | Public Health | 1 | 1997 | 438 | 0.030 |
Why?
| | Colorado | 1 | 2023 | 4113 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2019 | 722 | 0.030 |
Why?
| | Sex Factors | 2 | 2014 | 1736 | 0.020 |
Why?
| | Utah | 1 | 2011 | 60 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 1997 | 771 | 0.020 |
Why?
| | Odds Ratio | 1 | 2014 | 962 | 0.020 |
Why?
| | Population Surveillance | 1 | 1994 | 395 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1219 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 390 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 499 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2517 | 0.020 |
Why?
| | Goals | 1 | 2011 | 158 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2001 | 4665 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1997 | 1198 | 0.020 |
Why?
| | Triage | 1 | 2011 | 192 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2011 | 287 | 0.020 |
Why?
| | Pregnancy | 1 | 1997 | 5548 | 0.020 |
Why?
| | Iowa | 1 | 1994 | 25 | 0.010 |
Why?
| | Homicide | 1 | 1994 | 53 | 0.010 |
Why?
| | Bias | 1 | 1994 | 179 | 0.010 |
Why?
| | Accidental Falls | 1 | 1994 | 151 | 0.010 |
Why?
| | Suicide | 1 | 1994 | 501 | 0.000 |
Why?
|
|
Bennett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|